Page last updated: 2024-10-26

valproic acid and Allergic Encephalomyelitis

valproic acid has been researched along with Allergic Encephalomyelitis in 6 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"Valproic acid (VPA) is a short-chain branched fatty acid with anti-epileptic, neuro-protective and anti-inflammatory effects."5.46Valproic acid attenuates inflammation of optic nerve and apoptosis of retinal ganglion cells in a rat model of optic neuritis. ( Li, H; Liu, Q; Niu, X; Wang, Z; Yang, J; Zhao, C; Zhao, L, 2017)
"Valproic acid (VPA) is a short-chain branched fatty acid with anti-inflammatory, neuro-protective and axon remodeling effects."5.38Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats. ( Schluesener, HJ; Wu, Y; Zhang, Z; Zhang, ZY, 2012)
"Valproic acid (VPA) is a short-chain branched fatty acid with anti-epileptic, neuro-protective and anti-inflammatory effects."1.46Valproic acid attenuates inflammation of optic nerve and apoptosis of retinal ganglion cells in a rat model of optic neuritis. ( Li, H; Liu, Q; Niu, X; Wang, Z; Yang, J; Zhao, C; Zhao, L, 2017)
"Valproic acid (VPA) is a short-chain branched fatty acid with anti-inflammatory, neuro-protective and axon remodeling effects."1.38Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats. ( Schluesener, HJ; Wu, Y; Zhang, Z; Zhang, ZY, 2012)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Q1
Li, H1
Yang, J1
Niu, X1
Zhao, C1
Zhao, L1
Wang, Z1
Pazhoohan, S1
Satarian, L1
Asghari, AA1
Salimi, M1
Kiani, S1
Mani, AR1
Javan, M1
Castelo-Branco, G1
Stridh, P1
Guerreiro-Cacais, AO1
Adzemovic, MZ1
Falcão, AM1
Marta, M1
Berglund, R1
Gillett, A1
Hamza, KH1
Lassmann, H1
Hermanson, O1
Jagodic, M1
Azuchi, Y1
Kimura, A1
Guo, X1
Akiyama, G1
Noro, T1
Harada, C1
Nishigaki, A1
Namekata, K1
Harada, T1
Lv, J1
Du, C1
Wei, W1
Wu, Z1
Zhao, G1
Li, Z1
Xie, X1
Zhang, Z1
Zhang, ZY1
Wu, Y1
Schluesener, HJ1

Trials

1 trial available for valproic acid and Allergic Encephalomyelitis

ArticleYear
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
    The Journal of biological chemistry, 2012, Aug-17, Volume: 287, Issue:34

    Topics: Animals; Anticonvulsants; Caspase 3; Caspase 8; Drug Evaluation, Preclinical; Encephalomyelitis, Aut

2012

Other Studies

5 other studies available for valproic acid and Allergic Encephalomyelitis

ArticleYear
Valproic acid attenuates inflammation of optic nerve and apoptosis of retinal ganglion cells in a rat model of optic neuritis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 96

    Topics: Animals; Apoptosis; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; In Situ Nic

2017
Valproic Acid attenuates disease symptoms and increases endogenous myelin repair by recruiting neural stem cells and oligodendrocyte progenitors in experimental autoimmune encephalomyelitis.
    Neuro-degenerative diseases, 2014, Volume: 13, Issue:1

    Topics: Animals; Central Nervous System Agents; Encephalomyelitis, Autoimmune, Experimental; Female; Fluores

2014
Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.
    Neurobiology of disease, 2014, Volume: 71

    Topics: Analysis of Variance; Animals; Brain; CD11b Antigen; CD4-Positive T-Lymphocytes; Disease Models, Ani

2014
Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis.
    Neuroscience letters, 2017, 02-03, Volume: 639

    Topics: Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; MAP Kinase Kin

2017
Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
    Neuroscience, 2012, Sep-27, Volume: 221

    Topics: Animals; Anti-Inflammatory Agents; CD11b Antigen; CD3 Complex; Cell Proliferation; Cytokines; Diseas

2012